Maynard Um
-
-
-
-
-
-
-
Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders
-
-
-
-
-
-
-
Jaguar Health to Hold Investor Webcast May 26 Regarding Q1 2026 Financials & Corporate Updates; Jaguar CEO Lisa Conte Presenting May 28 at Lytham Partners Spring 2026 Investor Conference
-
-
-
-
-
-
-
Jaguar Health launches Neonorm Dog for canine digestive health
-
-
-
-
-
-
-
Jaguar Health plans AI integration for rare disease drug development
-
-
-
-
-
-
-
Jaguar Health receives FDA support for MVID trial extension phase
-
-
-
-
-
-
-
Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1
-
-
-
-
-
-
-
Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million
-
404,878 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

